North America Biochips Market Forecast 2019-2028

North America Biochips Market Forecast 2019-2028

The North America biochips market is evaluated to record a CAGR of 13.65% over the projected period of 2019-2028. Biochips are used for large-scale studies of gene expression applications and cancer treatment and diagnostics, which boost their adoption. Factors such as well-developed infrastructure, and rapid technological advancements in biochip technology are propelling market growth in the region.

The North America biochips market is researched further by segregating the region into the United States and Canada. The Canadian market has immense opportunities, and is dependent on the usage and acceptance of microfluidics technology within the country. In 2018, Micralyne launched the microfluidics technology, which is a highly usable and functional set of standardized microfluidic processes utilized in various biomedical applications. This technology has been developed to be utilized in devices such as biochips, cell sorters, flow cells, lab-on-a-chip, high-pressure analytical, and separation, and analysis devices. This novel technology is encouraging innovations in the field of microfluidics LOC in Canada. The higher acceptability of point-of-care testing is driving the demand for biochips in the country. The use of POCT has been increasing in Canadian healthcare recently, and this trend is expected to continue in the future. The conferences held on technologies such as genomics and microarrays are driving the demand for novel technologies in the country, thereby benefitting the biochips market. Canada has a strong international reputation in cutting-edge R&D, with 60% of the top-cited researchers surveyed internationally. Also, the country has the world’s leading infrastructure and conducts related programs.

Some of the prominent companies functioning in the market are Abbott Laboratories, Illumina, Inc, Agilent Technologies, Inc, Thermo Fisher Scientific Inc, Cepheid, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Parent Market Analysis: Genomics And Proteomics Market
3.2. Development Of Biochips
3.3. Market Definition
3.4. Key Drivers
3.4.1. Rising Incidences Of Chronic Diseases
3.4.2. Growing Interest In Personalized Medicines
3.4.3. Application Of Proteomics And Genomics In Cancer Research
3.4.4. Rapidly Growing Use Of Point-of-care Testing Diagnostics
3.5. Key Restraints
3.5.1. High Instrumentation Cost
3.5.2. Lack Of Awareness Among Common People About Biochip Technology
3.5.3. Availability Of Alternative Technology: Next Generation Sequencing (Ngs) Technology
3.5.4. Complexity Of Biological Systems
3.5.5. Lack Of Common Regulatory Standards
4. Key Analytics
4.1. Impact Of Covid-19 On Biochips
4.2. Key Investment Insights
4.3. Porter’s Five Force Analysis
4.3.1. Buyer Power
4.3.2. Supplier Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.6.1. Research & Development
4.6.2. Raw Materials
4.6.3. Manufacturing
4.6.4. Wholesalers/Retailers/Distributors
4.6.5. End-user
4.7. Key Buying Criteria
4.7.1. Cost
4.7.2. Applications
4.7.3. Product Type
4.8. Regulatory Framework
5. Market By Type
5.1. Dna Chips
5.1.1. Agricultural Biotechnology
5.1.2. Cancer Diagnosis & Treatment
5.1.3. Drug Discovery
5.1.4. Gene Expression
5.1.5. Genomics
5.1.6. Single Nucleotide Polymorphism (Snp) Genotyping
5.1.7. Other Dna Chips
5.2. Lab On A Chip
5.2.1. Clinical Diagnostics
5.2.2. Drug Discovery
5.2.3. Genomics
5.2.4. Point Of Care & In Vitro Diagnosis
5.2.5. Proteomics
5.2.6. Other Lab On A Chip
5.3. Protein Chips
5.3.1. Diagnostics
5.3.2. Drug Discovery
5.3.3. Expression Profiling
5.3.4. High Throughput Screening
5.3.5. Proteomics
5.3.6. Other Protein Chips
5.4. Other Types
5.4.1. Cell Arrays
5.4.2. Tissue Arrays
6. Market By Substrate Materials
6.1. Glass
6.2. Polymers
6.3. Silicon
6.4. Other Substrate Materials
7. Market By End-user
7.1. Biotechnology And Pharmaceutical Companies
7.2. Hospitals And Diagnostics Centers
7.3. Academic And Research Institutes
8. Geographical Analysis
8.1. North America
8.1.1. United States
8.1.2. Canada
9. Company Profiles
9.1. Abbott Laboratories Inc
9.2. Agilent Technologies Inc
9.3. Biochain Institute Inc
9.4. Biomérieux Sa
9.5. Bio-rad Laboratories Inc
9.6. Cepheid
9.7. Cybrdi Inc
9.8. F Hoffmann-la Roche Ltd
9.9. Fluidigm Corporation
9.10. Ge Healthcare
9.11. Illumina Inc
9.12. Merck Kgaa
9.13. Perkinelmer Inc
9.14. Randox Laboratories Ltd
9.15. Thermo Fisher Scientific Inc

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook